Stay updated on Dapagliflozin Impact on T2DM Risk Factors Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    There are no additions or deletions to report. The page content appears unchanged with respect to the study details and related sections.
    Difference
    0.1%
    Check dated 2026-08-01T23:14:44.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page revision line was updated from v3.6.3 to v3.6.4. This indicates a minor update to the page's version metadata rather than to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T18:26:06.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous v3.6.2, indicating a minor version update to the study record page. This metadata change does not modify the study details.
    Difference
    0.1%
    Check dated 2026-07-04T04:47:20.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.6.0 to v3.6.2, reflecting a minor update to the page version without changing its content.
    Difference
    0.1%
    Check dated 2026-06-27T03:18:28.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The page now includes related topics such as Type 2 diabetes and MedlinePlus Genetics, adding links to genetics-related health information.
    Difference
    0.2%
    Check dated 2026-06-19T22:52:58.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    The Study Details page now includes Manfredi Rizzo as part of the study record information and adds new navigation items such as How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment label. Legacy text such as Last known status was, Verified, Manfredi Rizzo, University of Palermo, Intervention / Treatment, and the prior Revision: v3.5.5 has been removed, with Revision: v3.6.0 introduced.
    Difference
    2%
    Check dated 2026-06-12T16:40:08.000Z thumbnail image

Stay in the know with updates to Dapagliflozin Impact on T2DM Risk Factors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.